News & Press Releases
Filter by:
SEC’s Pharmaceutical Insider Trading Case Yields Quick Deals
August 19, 2025
Bloomberg Law featured a statement from Member Jason P.W. Halperin in its coverage of a pharmaceutical insider trading case brought by the SEC. Jason and the Mintz team of Sean Prosser and Elizabeth Platonova represented Robert Yedid in reaching a resolution in which the client pled guilty and, along with the other defendants, entered into consent orders with the SEC.
Mintz Advises Oppenheimer & Co. and Initial Purchasers in $475M Convertible Senior Notes Offering by WisdomTree
August 19, 2025
Mintz represented Oppenheimer & Co., as sole book-running manager, and Craig-Hallum Capital Group and Northland Securities, as co-managers, in the private placement of $475 million aggregate principal amount of 4.625% Convertible Senior Notes due 2030 issued by WisdomTree, Inc (NYSE: WT) (“WisdomTree”). The notes were sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.
Of Counsel Michelle Capezza recently shared insights with Fiduciary News in light of the recent "Democratizing Access to Alternative Assets for 401(K) Investors" executive order. The article emphasizes that fiduciaries must respond quickly and carefully to new regulations, protecting participants while adapting to a more complex retirement landscape.
Mintz Advises Underwriters in Assembly Biosciences' $175 Million Underwritten Offering and Concurrent Private Placement
August 18, 2025
Mintz advised the underwriters in connection with Assembly Biosciences, Inc.’s underwritten offering of an aggregate of 5,591,840 shares of common stock and pre-funded warrants to purchase up to 1,040,820 shares of common stock, together with accompanying Class A and Class B warrants to purchase up to an aggregate of 6,632,660 shares of common stock at a combined price per share of common stock and accompanying Class A warrant and Class B warrant of $19.60 and a combined price per pre-funded warrant and accompanying Class A warrant and Class B warrant of $19.599.
How AI Is Disrupting LevFin, Part One — When Intangible Assets Become Tangibly Risky
August 18, 2025
Member Marguerite McConihe was quoted by 9fin in an article about the opportunities and risks associated with the use of AI technologies in leveraged finance. The article notes that while LevFin bankers have largely benefitted from AI, questions are emerging around credit risk, cyber security vulnerabilities, and treating AI-generated assets or IP as debt collateral.
Data Centers Shift Investor Strategy Away from Acquisitions
August 18, 2025
CRE Daily quoted Member Jeffrey Moerdler in an article about how investors are increasingly seeking new builds rather than acquisitions of older data centers as AI-driven demand continues. Some industry leaders suggest that this trend may be overlooking the opportunities offered by existing assets.
